Skip to main content

Table 3 Demographics, comparison of subjects with and without % DLCO measurements

From: Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study

 

Subjects with DLCO

Subjects without DLCO

p-value

Sample size

53

20

-

Age, years*

64 (1)

61 (2)

0.16

Sex, M/F

32/21

10/10

0.43

Pack years*

54 (3)

49 (5)

0.49

Current smokers (%)

15 (28)

4 (20)

0.48

ICS use (%)

24 (45)

12 (60)

0.27

SCS use (%)

3 (6)

2 (10)

0.52

% FEV1 *

51 (4)

51 (6)

0.97

FEV1/FVC*

45 (2)

46 (4)

0.89

  1. *Data are presented as mean (SEM).